Mostrar el registro sencillo del ítem
| dc.contributor.author | López-Manzanares, Lydia | |
| dc.contributor.author | Cerdán-Sánchez, María | |
| dc.contributor.author | Solano-Vila, Berta | |
| dc.contributor.author | Delgado-Ballestero, Tania | |
| dc.contributor.author | García-Ramos, Rocio | |
| dc.contributor.author | García-Caldentey, Juan | |
| dc.contributor.author | Rodríguez-Sanz, Ana | |
| dc.contributor.author | Olivares-Romero, Jesús | |
| dc.contributor.author | Gaston, Itziar | |
| dc.contributor.author | Carmona-Abellan, Mar | |
| dc.contributor.author | Mata-Álvarez-Santullano, Marina | |
| dc.contributor.author | Vázquez-Picon, Raquel | |
| dc.contributor.author | Rodríguez-de-Miguel, Marta | |
| dc.contributor.author | Tegel-Ayuela, Iciar | |
| dc.contributor.author | Magalhaes, Diogo | |
| dc.contributor.author | Holenz, Joerg | |
| dc.date.accessioned | 2026-11-11T09:05:27Z | |
| dc.date.available | 2026-11-11T09:05:27Z | |
| dc.date.issued | 2026-09-11 | |
| dc.identifier.citation | López-Manzanares L, Cerdán Sánchez M, Solano Vila B, Delgado Ballestero T, García-Ramos R, García Caldentey J, et al. Real-World Use of Opicapone in Management of Patients with Parkinson's Disease and Early Motor Fluctuations in Spain: 12-Month Interim Analysis of REONPARK Study. Brain Sci. 11 de septiembre de 2026;16(9):961. doi:10.3390/brainsci16090961 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/29166 | |
| dc.description.abstract | Objective: To evaluate the sustained real-world effectiveness and safety of catechol-O-methyltransferase (COMT) inhibitors added to levodopa in patients with Parkinson's disease (PD) presenting early motor fluctuations. Methods: REONPARK is an ongoing, multicenter, prospective observational study conducted in Spain. Adult patients with PD and end-of-dose motor fluctuations for <2 years initiating a COMT inhibitor were included. Outcomes assessed at 3, 6, and 12 months included Clinician and Patient Global Impression of Change (CGI-C, PGI-C), Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Wearing-off Questionnaire (WOQ-19), Non-Motor Symptoms Scale (NMSS), Parkinson's Disease Questionnaire-8 (PDQ-8), and safety. This article presents the 3-, 6-, and 12-month planned interim analysis of the study. Results: A total of 143 patients were included (99.3% treated with opicapone), of whom 138, 131, and 89 patients completed the 3, 6, and 12 months of follow-up, respectively. Levodopa doses remained stable in most patients (73% at 12 months). Significant and sustained improvements were observed in MDS-UPDRS Parts III and IV scores, as well as the total MDS-UPDRS score over 12 months, with greater likelihood of Part IV improvement in patients receiving <4.5 mg/kg/day of levodopa. OFF time decreased by 1.6-2.0 h from baseline. ON-time quality was maintained over time with 97.7% of patients reporting no or minimal functional impact from dyskinesia, while 47.7% of patients had no impact from motor fluctuations and 36.4% of patients no longer experienced OFF periods at 12 months. PDQ-8 scores remained stable and no overall benefit on total non-motor symptoms burden was demonstrated, despite improvements in selected domains among patients with a higher baseline non-motor symptoms burden. WOQ-19 scores improved significantly. Conclusions: In PD patients with early motor fluctuations, opicapone initiation was associated with sustained improvements in motor outcomes and reduced OFF time, and maintained the ON-time quality over 12 months, with stable levodopa dosing. | |
| dc.language.iso | eng | |
| dc.publisher | MDPI | |
| dc.rights | Atribución/Reconocimiento 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/deed.es | * |
| dc.title | Real-World Use of Opicapone in Management of Patients with Parkinson's Disease and Early Motor Fluctuations in Spain: 12-Month Interim Analysis of REONPARK Study | |
| dc.type | info:eu-repo/semantics/article | |
| dc.relation.publisherversion | https://www.mdpi.com/2076-3425/16/9/961 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.3390/brainsci16090961 | |
| dc.journal.title | Brain Sciences | |
| dc.identifier.essn | 2076-3425 |